Key informationObjectiveAnalysis of safety parameters and biomarkers of intestinal microbiotaStudy design-...
![[CASE STUDY] Pharma clinical study in patients treated for cancer](https://www.biofortis.fr/wp-content/uploads/2023/07/HERACLES-940x675.png)
Key informationObjectiveAnalysis of safety parameters and biomarkers of intestinal microbiotaStudy design-...
Key informationObjectiveAnalysis of intestinal microbiotaStudy design- Multicentre, in France- A nine-year-long...
Key informationObjectiveAnalysis of cardiac biomarkersStudy design- International multicentric: Europe, Australia,...
Key informationObjectiveAnalysis of intestinal microbiotaStudy design- National study in France- Observational studyOur missionKitting for sample collection at room temperature main challenge- Large scale of sampling kit production
Key informationObjectiveAnalysis of safety parameters and biomarkers of intestinal microbiotaStudy design- Multinational multicentric: France, Germany, Italy and Poland- Phase II interventional study- 24 patients includedOur missionKittingSample analysisLogisticsmain...
Key informationObjectiveAnalysis of intestinal microbiotaStudy design- Multicentre, in France- A nine-year-long observational study- 300 patients includedOur missionKittingMicrobiome analysesLogisticsmain challenges- Technological continuity over...
Key informationObjectiveAnalysis of cardiac biomarkersStudy design- International multicentric: Europe, Australia, Middle East, Asia- Observational study- 200 patients includedOur missionKittingSample analysisLogisticsmain challenges- Long study duration versus...
Key informationObjectiveAnalysis of immunological and liver markersStudy design- International multicentre: Belgium, Bulgaria, France and Spain- Phase I/II interventional studyOur missionSample analysismain challenges- Interaction with multiple partners...